BioMotiv
Accelerating Breakthrough Discoveries into Medicines

News

News

Posts in Press Release
Sujana Biotech Receives NIH Grant

Sujana Biotech announces funding from the National Heart Lung and Blood Institute to support the development of a novel anti-thrombotic therapeutic. BioAtla, a long time collaborator, was awarded a Phase I SBIR grant of $220,268 to support the development of Sujana’s platform technology. The technology has potential applications over a range of inflammatory and vascular disorders.

Read More
Dr. Daniel I. Simon, Founder of Sujana Biotech, Receives American College of Cardiology Top Honor

In April, Dr. Simon will be presented with the 2016 Distinguished Scientist Award Basic Domain by the American College of Cardiology at the ACC’s 65th Annual Scientific Session. The award is in honor of his lasting contributions and achievements in the cardiovascular profession, and his dedication to both patient care and clinical research. Dr. Simon serves as the President of University Hospitals Case Medical Center and the UH Harrington Heart & Vascular Institute. Sujana Biotech (www.sujanabio.com) is based on his discoveries.

Read More